QS Investors’s NEVRO CORP. NVRO Stock Holding History

QS Investors’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,630	Closed	-$367K	–	1248
2021 Q1	$367K	Sell	2,630 -2,570	-49%	-$419K	﹤0.01%	907
2020 Q4	$900K	Hold	5,200	–	–	0.01%	537
2020 Q3	$725K	Sell	5,200 -21,900	-81%	-$2.93M	0.01%	556
2020 Q2	$3.24M	Sell	27,100 -800	-3%	-$94.9K	0.05%	323
2020 Q1	$2.79M	Buy	27,900 +1,100	+4%	+$132K	0.04%	318
2019 Q4	$3.16M	Sell	26,800 -300	-1%	-$29.7K	0.03%	428
2019 Q3	$2.33M	Hold	27,100	–	–	0.03%	518
2019 Q2	$1.76M	Buy	+27,100	New	+$1.69M	0.02%	632
2018 Q2	–	Sell	-500	Closed	-$43K	–	1977
2018 Q1	$43K	Hold	500	–	–	﹤0.01%	1494
2017 Q4	$35K	Hold	500	–	–	﹤0.01%	1516
2017 Q3	$45K	Hold	500	–	–	﹤0.01%	1543
2017 Q2	$37K	Hold	500	–	–	﹤0.01%	1563
2017 Q1	$47K	Buy	+500	New	+$45.3K	﹤0.01%	1544
2016 Q4	–	Sell	-4	Closed	-$1K	–	1964
2016 Q3	$1K	Hold	4	–	–	﹤0.01%	1795
2016 Q2	$1K	Buy	+4	New	+$271	﹤0.01%	1851

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

QS Investors's NVRO Position: Q2 2021 in Review

QS Investors sold out of NEVRO CORP. (NVRO) in Q2 2021, closing a stake of 2,630 shares — an estimated $367K sold.

QS Investors first reported a position in NVRO in Q2 2016 and held it in 15 quarters. The position peaked at $3.24M in Q2 2020. 207 funds tracked by Wall St. Rank hold NVRO as of Q2 2021.

QS Investors reported no remaining NEVRO CORP. position as of Q2 2021 after selling out during the quarter.
QS Investors sold 2,630 NEVRO CORP. shares in Q2 2021, an estimated $367K.
QS Investors first reported a position in NEVRO CORP. in Q2 2016 and held it in 15 quarters.
QS Investors's NEVRO CORP. position peaked at $3.24M in Q2 2020.
207 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.